Dehdashti F - Search Results

1

PET Radiotracers for Imaging the Proliferative Status of Solid Tumors.

Mach RH, Dehdashti F, Wheeler KT. Mach RH, et al. Among authors: dehdashti f. PET Clin. 2009 Jan 1;4(1):1-15. doi: 10.1016/j.cpet.2009.04.012. PET Clin. 2009. PMID: 20046891 Free PMC article.

2

Assessment of cellular proliferation in tumors by PET using 18F-ISO-1.

Dehdashti F, Laforest R, Gao F, Shoghi KI, Aft RL, Nussenbaum B, Kreisel FH, Bartlett NL, Cashen A, Wagner-Johnston N, Mach RH. Dehdashti F, et al. J Nucl Med. 2013 Mar;54(3):350-7. doi: 10.2967/jnumed.112.111948. Epub 2013 Jan 28. J Nucl Med. 2013. PMID: 23359657 Free PMC article.

3

The Emerging Role of PET/MR Imaging in Gynecologic Cancers.

Ponisio MR, Fowler KJ, Dehdashti F. Ponisio MR, et al. Among authors: dehdashti f. PET Clin. 2016 Oct;11(4):425-40. doi: 10.1016/j.cpet.2016.05.005. PET Clin. 2016. PMID: 27593247 Review.

4

Percutaneous Minimally Invasive Thermal Ablation of Musculoskeletal Lesions: Usefulness of PET-Computed Tomography.

Tomasian A, Dehdashti F, Jennings JW. Tomasian A, et al. Among authors: dehdashti f. PET Clin. 2018 Oct;13(4):579-585. doi: 10.1016/j.cpet.2018.05.010. Epub 2018 Aug 17. PET Clin. 2018. PMID: 30219189 Review.

5

Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET.

Laforest R, Dehdashti F, Lewis JS, Schwarz SW. Laforest R, et al. Among authors: dehdashti f. Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):764-70. doi: 10.1007/s00259-004-1756-x. Epub 2005 Mar 23. Eur J Nucl Med Mol Imaging. 2005. PMID: 15785955

6

Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone).

Dehdashti F, Grigsby PW, Lewis JS, Laforest R, Siegel BA, Welch MJ. Dehdashti F, et al. J Nucl Med. 2008 Feb;49(2):201-5. doi: 10.2967/jnumed.107.048520. Epub 2008 Jan 16. J Nucl Med. 2008. PMID: 18199612 Free article.

7

An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix.

Lewis JS, Laforest R, Dehdashti F, Grigsby PW, Welch MJ, Siegel BA. Lewis JS, et al. Among authors: dehdashti f. J Nucl Med. 2008 Jul;49(7):1177-82. doi: 10.2967/jnumed.108.051326. Epub 2008 Jun 13. J Nucl Med. 2008. PMID: 18552145 Free PMC article.

8

18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation.

Cashen AF, Dehdashti F, Luo J, Homb A, Siegel BA, Bartlett NL. Cashen AF, et al. Among authors: dehdashti f. J Nucl Med. 2011 Mar;52(3):386-92. doi: 10.2967/jnumed.110.082586. Epub 2011 Feb 14. J Nucl Med. 2011. PMID: 21321279 Free PMC article.

9

Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione.

Dehdashti F, Laforest R, Gao F, Aft RL, Dence CS, Zhou D, Shoghi KI, Siegel BA, Katzenellenbogen JA, Welch MJ. Dehdashti F, et al. J Nucl Med. 2012 Mar;53(3):363-70. doi: 10.2967/jnumed.111.098319. Epub 2012 Feb 13. J Nucl Med. 2012. PMID: 22331216 Free PMC article.

10

Measurement Repeatability of ¹⁸F-FDG PET/CT Versus ¹⁸F-FDG PET/MRI in Solid Tumors of the Pelvis.

Fraum TJ, Fowler KJ, Crandall JP, Laforest RA, Salter A, An H, Jacobs MA, Grigsby PW, Dehdashti F, Wahl RL. Fraum TJ, et al. Among authors: dehdashti f. J Nucl Med. 2019 Aug;60(8):1080-1086. doi: 10.2967/jnumed.118.218735. Epub 2019 Feb 7. J Nucl Med. 2019. PMID: 30733325 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters